Skip to Content


In the US, Avelox (moxifloxacin systemic) is a member of the drug class quinolones and is used to treat Bacterial Infection, Bronchitis, Intraabdominal Infection, Plague, Plague Prophylaxis, Pneumonia, Sinusitis, Skin and Structure Infection, Skin or Soft Tissue Infection and Tuberculosis - Active.

US matches:

UK matches:

Ingredient matches for Avelox


Moxifloxacin is reported as an ingredient of Avelox in the following countries:

  • Georgia
  • Latvia
  • Peru
  • Russian Federation
  • Turkey

Moxifloxacin hydrochloride (a derivative of Moxifloxacin) is reported as an ingredient of Avelox in the following countries:

  • Australia
  • Belgium
  • Bosnia & Herzegowina
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia (Hrvatska)
  • Czech Republic
  • Denmark
  • Ecuador
  • Estonia
  • Finland
  • Georgia
  • Greece
  • Hong Kong
  • Hungary
  • Ireland
  • Japan
  • Lithuania
  • Malaysia
  • Malta
  • Mexico
  • Netherlands
  • New Zealand
  • Pakistan
  • Philippines
  • Poland
  • Portugal
  • Romania
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Korea
  • Sweden
  • Taiwan
  • Thailand
  • United Kingdom
  • United States
  • Vietnam

International Drug Name Search

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.